Washington D.C., Jan 24, 2005 / 22:00 pm
The Federal Drug Administration has delayed its decision about whether to make the morning-after pill available over the counter. The morning-after pill is also known as Plan B.
The FDA had aimed to have a decision by Jan. 21, but Barr Pharmaceuticals said in a statement Friday that the FDA told the company it was unable to complete its review by then.
According the statement, the FDA said, "it is committed to completing its review of the application in the near future."
The FDA had rejected the over-the-counter proposal last year, stating that there was a lack of information about the drug’s effect on teenagers.